Citicoline
500 mg of CDP-Choline — the dual-function phospholipid precursor that fuels acetylcholine synthesis and builds synaptic membranes simultaneously, while increasing frontal lobe ATP by 14% in a small within-subjects study (n=16, no placebo control).
Primacy Research
What Citicoline Does For You
+14% Frontal Lobe ATP
Phosphorus MRS brain imaging showed 500 mg/day citicoline increased frontal lobe ATP by 14% and phosphocreatine by 7% in just 6 weeks — direct evidence of enhanced brain energy metabolism at the exact APEX dose.
Dual-Payload Acetylcholine + Membranes
Citicoline is uniquely hydrolyzed into choline (for acetylcholine synthesis) and cytidine (for CTP/membrane production) — feeding both the neurotransmitter and the structural pathway from a single molecule.
Stops Membrane Autocannibalism
By providing exogenous choline, citicoline prevents neurons from stripping their own membrane phospholipids to produce acetylcholine — halting the self-destructive cycle that accelerates with age and cognitive demand.
Improved Episodic Memory
A 12-week RCT (Nakazaki et al., 2021) in healthy older adults demonstrated significant episodic memory improvement at 500 mg/day — the exact dose delivered in APEX.
100% Bioavailability
CDP-choline is completely absorbed and hydrolyzed after oral ingestion — no waste. Both metabolites (cytidine and choline) cross the blood-brain barrier independently via dedicated transporters.
Your Brain Is Cannibalizing Its Own Membranes
Under sustained cognitive load, your brain burns through acetylcholine — the neurotransmitter of attention, memory encoding, and executive function. When free choline runs out, neurons strip choline from their own membrane phospholipids to keep acetylcholine production going. This ‘autocannibalism’ degrades the very synaptic membranes that neurotransmission depends on — a self-destructive cycle that accelerates with age.
Cholinergic Decline
Acetylcholine output and cholinergic neuron density decline steadily from age 40. ChAT (the enzyme that produces ACh) loses ~5–10% activity per decade. By middle age, the cholinergic system that drives attention and memory encoding is operating on diminished capacity.
Membrane Autocannibalism
When cognitive demand outpaces choline supply, neurons activate phospholipase D to harvest choline from membrane phosphatidylcholine. Each ACh molecule produced this way comes at the cost of membrane integrity — degrading receptor density, ion channel function, and signal transduction.
Brain Energy Deficit
Phosphorus MRS imaging reveals that frontal lobe bioenergetics (phosphocreatine, ATP) decline with age and cognitive load. Less cellular energy means slower processing speed, reduced working memory capacity, and impaired sustained attention.
How Citicoline Works
Citicoline (cytidine 5’-diphosphocholine) is hydrolyzed after ingestion into two bioactive components — cytidine and choline — that enter the brain independently. This dual-payload design makes citicoline uniquely efficient: it feeds both acetylcholine synthesis and the Kennedy pathway for membrane phospholipid production from a single molecule.
Dual-Payload Hydrolysis
Oral citicoline is absorbed with ~100% bioavailability and split into cytidine and choline in the gut and liver. Both metabolites enter systemic circulation and cross the blood-brain barrier independently — cytidine via nucleoside transporters, choline via the choline transporter.
Choline → Acetylcholine
Free choline enters cholinergic neurons and is converted to acetylcholine by choline acetyltransferase (ChAT). By providing exogenous choline, citicoline reduces the reliance on membrane-derived choline for acetylcholine production — neurons no longer need to strip their own membranes for ACh production.
Choline + Cytidine → Kennedy Pathway
Choline is also phosphorylated to phosphocholine. Cytidine is converted to uridine → UTP → CTP, which drives the rate-limiting step of the Kennedy pathway: CTP + phosphocholine → CDP-choline → phosphatidylcholine. Citicoline uniquely supplies BOTH the choline substrate and the CTP energy currency.
Phospholipid Membrane Synthesis
The Kennedy pathway produces phosphatidylcholine — the most abundant phospholipid in neuronal membranes (~40–50% of total). Adequate PC maintains membrane fluidity, receptor density, ion channel function, and synaptic vesicle recycling. Citicoline also supports sphingomyelin and cardiolipin synthesis.
Frontal Lobe Bioenergetics
Silveri et al. (2008) demonstrated via phosphorus MRS that 500 mg/day citicoline for 6 weeks increased frontal lobe phosphocreatine by ~7% and ATP (beta-NTP) by ~14% — direct evidence of enhanced brain energy metabolism at the APEX dose.
What the Research Shows
Citicoline (Cognizin) is backed by multiple randomized, controlled trials demonstrating benefits for memory, attention, and brain bioenergetics at the 500 mg dose used in APEX.
Nakazaki et al. (2021). Journal of Nutrition, 151(8):2153-2160. 500 mg/day Cognizin citicoline. Significant episodic memory improvement vs. placebo.
Silveri et al. (2008). NMR in Biomedicine, 21(10):1066-1075. 500 mg/day Cognizin. Phosphorus MRS brain imaging.
McGlade et al. (2012). Food and Nutrition Sciences, 3(6):769-773. 250 mg and 500 mg Cognizin. Healthy women aged 40-60. 500 mg produced more consistent attentional improvement.
Your Daily Dose in APEX
Why this dose works: 500 mg is the sweet spot of the clinical evidence — validated for attention (McGlade 2012), episodic memory (Nakazaki 2021), and frontal lobe bioenergetics (Silveri 2008). The 1,000 mg studies targeted impaired populations (AAMI, post-stroke). For healthy cognitive optimization, 500 mg delivers the full clinical effect with 100% bioavailability.
How Citicoline Connects Across the System
Citicoline doesn’t work in isolation. Inside the Primacy protocol, it sits at the center of the cholinergic system, the Kennedy pathway membrane engine, and circadian architecture spanning both APEX and RESET.
The Kennedy Pathway Engine
Citicoline and Uridine together saturate two of three Kennedy pathway inputs — choline for the head group and CTP for the rate-limiting cytidylyltransferase step. Citicoline uniquely provides BOTH: its cytidine moiety converts to CTP while its choline feeds the substrate arm. Adding exogenous UMP (250 mg) is designed to prevent CTP from becoming rate-limiting. The third input — DHA — arrives overnight from RESET’s AvailOm®.
The Cholinergic Optimization Stack
Citicoline provides the substrate (choline). Cereboost® inhibits the breakdown enzyme (AChE) and upregulates the production enzyme (ChAT). Together they attack the cholinergic system at three leverage points: more substrate, faster production, slower degradation. This is the pharmacological equivalent of increasing supply while simultaneously reducing waste.
Circadian Membrane Architecture
The brain’s membrane factory (Kennedy pathway) needs three inputs: CTP, choline, and DHA. APEX loads the first two during the day. RESET provides DHA overnight. During sleep, the brain consolidates the day’s synaptic remodeling — incorporating DHA into the phospholipid membranes built on the CTP + choline scaffold from APEX. The circadian split is deliberate: load the machinery by day, build the structure by night.
Key Takeaways
+14% Frontal Lobe ATP
Silveri et al. (2008) used phosphorus MRS brain imaging to demonstrate that 500 mg/day citicoline increased frontal lobe ATP by 14% and phosphocreatine by 7% in just 6 weeks — objective, brain-imaged evidence of enhanced bioenergetics at the exact APEX dose.
Dual-Payload Architecture
Citicoline is among the few cognitive supplements that simultaneously feed both acetylcholine synthesis (via choline) and synaptic membrane construction (via choline + CTP). One molecule, two outputs — reducing the reliance on membrane-derived choline for acetylcholine production.
Kennedy Pathway Engine
With Uridine (250 mg), citicoline saturates the membrane synthesis pathway. With AvailOm® DHA in RESET, the full triad is in place — replicating the Wurtman lab protocol that increased dendritic spine density by ~30% in a gerbil model using UMP + DHA (not citicoline directly).
Cholinergic Stack, Not Standalone
Inside APEX, citicoline connects to Cereboost® (AChE inhibition + ChAT upregulation), Magtein® (synaptogenesis demand), TyroPure™ (dopamine receptor upregulation), and caffeine (synergistic attention). It’s the substrate that makes the cholinergic system function.
Frequently Asked Questions
What is citicoline (CDP-choline)?
Citicoline (cytidine 5’-diphosphocholine) is a naturally occurring compound found in every cell. When taken orally, it is hydrolyzed into cytidine and choline — two precursors that independently cross the blood-brain barrier to support both acetylcholine production and synaptic membrane synthesis via the Kennedy pathway.
What is the difference between citicoline and alpha-GPC?
Both provide choline for acetylcholine synthesis, but citicoline uniquely provides cytidine as well — which converts to CTP, the energy currency that drives the Kennedy pathway for membrane production. Alpha-GPC delivers only choline. Citicoline is a dual-payload molecule; alpha-GPC is a single-payload one.
How does citicoline increase brain energy?
Silveri et al. (2008) used phosphorus MRS brain imaging to show that 500 mg/day citicoline increased frontal lobe ATP (beta-NTP) by 14% and phosphocreatine by 7% over 6 weeks. The mechanism involves enhanced mitochondrial membrane integrity and phospholipid turnover in neural tissue.
What is the Kennedy pathway?
The Kennedy pathway is the biochemical pathway that synthesizes phosphatidylcholine — the most abundant phospholipid in neuronal membranes. It requires three inputs: CTP (from uridine/cytidine), choline, and DHA. Citicoline uniquely supplies both choline and CTP precursor (cytidine) from a single molecule.
How much citicoline is in APEX?
APEX delivers 500 mg of citicoline per serving — the dose validated by Nakazaki (2021) for episodic memory, Silveri (2008) for brain bioenergetics, and McGlade (2012) for attention. This is the clinical sweet spot for healthy cognitive optimization.
Can I take citicoline with other nootropics?
Yes — citicoline is designed to work synergistically within APEX. It pairs with Uridine (Kennedy pathway co-substrate), Cereboost® (AChE inhibition to preserve the acetylcholine it produces), and the BDNF stack (CognatiQ® + Sabroxy® + Magtein®) which creates the synaptic growth demand that citicoline’s membrane supply fulfills.
References
- [1]Nakazaki, E., Mah, E., Saez, C., Difelice, S., & Buber, T. (2021). Citicoline and memory function in healthy older adults: a randomized, double-blind, placebo-controlled clinical trial. Journal of Nutrition, 151(8), 2153–2160.View
- [2]Silveri, M. M., Dikan, J., Ross, A. J., Jensen, J. E., Kamber, T., Kawada, Y., Renshaw, P. F., & Yurgelun-Todd, D. A. (2008). Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR in Biomedicine, 21(10), 1066–1075.View
- [3]McGlade, E., Locatelli, A., Hardy, J., Kamber, T., & Yurgelun-Todd, D. (2012). Improved attentional performance following citicoline administration in healthy adult women. Food and Nutrition Sciences, 3(6), 769–773.View
Upgrade Your Cholinergic Architecture
Citicoline is one of 28 active ingredients in APEX, engineered to work as a system — not a stack of standalone compounds.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.